cannabidiol for epilepsy | |||||
NEWS | |||||
Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in ... - BioSpace Meaningful 50% responder rates in subgroups of highly refractory seizure patients on concomitant medications cannabidiol (n=12) or everolimus ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |